Shope led a high-profile investigation, with
Joshua Lederberg and Stanley Oaks, into the risks posed by
emerging infectious diseases and the measures necessary to respond to them for the
Institute of Medicine. The findings were published in 1992 as
Emerging Infections: Microbial Threats to Health in the United States, with Shope as the principal author, and the publication was swiftly recognised as groundbreaking. It suggested that the success of
vaccines and
antibiotics had led to the threat of infectious diseases being underestimated. Shope stated at the press conference announcing the report's publication: "The medical community and society at large have tended to view acute infectious diseases as a problem of the past. But that assumption is wrong. We claimed victory too soon." The report was important in improving the detection of infectious diseases in the US, and has been credited with stimulating renewed global interest in the area. Shope continued to advise the US government on the topic later in the 1990s, and contributed to the establishment of American and international surveillance programs for infectious diseases including
ProMED. Shope was one of seven scientists to brief
Bill Clinton and
Al Gore in 1997 on the effects of
climate change, warning that the range of
mosquitoes and other
arthropod vectors would increase, affecting the prevalence of
dengue,
malaria and other infectious diseases. He also served on the
WHO Expert Panel on Virus Diseases and the
International Committee on Taxonomy of Viruses, as well as numerous committees and expert panels for US national bodies including the Institute of Medicine,
National Institutes of Health and
National Research Council. He was one of the co-editors of
Fields Virology, the "definitive" virology text. ==Personal life==